← 產業報告目錄
Acquired Orphan Blood Disease Market Size, Share & Trends Analysis Report, By Therapy, By Disease Indication, By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), By Region, And by Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-10頁數 180報告編號 INSIGHTACE-27ef7eed7a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 9.4 Billion, the global Acquired Orphan Blood Disease Market is anticipated to expand to USD 26.1 Billion by 2034, demonstrating a CAGR of 10.8% during the 2025–2034 forecast window.
Acquired Orphan Blood Disease covers key industry insights & findings from the report:
A key trend in the market is the development of targeted therapies and personalized medicine approaches, which aim to provide more precise and effici. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is driven by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Acquired Orphan Blood Disease Market Snapshot
Chapter 4. Global Acquired Orphan Blood Disease Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Therapy Estimates & Trend Analysis
5.1. by Therapy & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Therapy:
5.2.1. Recombinant Factor
5.2.2. Immunoglobulin Infusion Therapy
5.2.3. Activated Prothrombin Complex Concentrate
5.2.4. Thrombopoietin Receptor Agonists
5.2.5. Others
Chapter 6. Market Segmentation 2: by Disease Indication Estimates & Trend Analysis
6.1. by Disease Indication & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Disease Indication:
6.2.1. Acquired Agranulocytosis
6.2.2. Acquired Hemophilia
6.2.3. Acquired Von Willebrand Syndrome
6.2.4. Paroxysmal Nocturnal Hemoglobinuria (PNH)
6.2.5. Myelodysplastic Syndrome
6.2.6. Other
Chapter 7. Market Segmentation 3: by Distribution Channel Estimates & Trend Analysis
7.1. by Distribution Channel & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
7.2.1. Hospital Pharmacy
7.2.2. Retail Pharmacy
7.2.3. Others
Chapter 8. Acquired Orphan Blood Disease Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
8.1.2. North America Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
8.1.3. North America Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
8.1.4. North America Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
8.2.2. Europe Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
8.2.3. Europe Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
8.2.4. Europe Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
8.3.2. Asia Pacific Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
8.3.3. Asia-Pacific Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
8.3.4. Asia Pacific Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
8.4.2. Latin America Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
8.4.3. Latin America Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
8.4.4. Latin America Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
8.5.2. Middle East & Africa Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
8.5.3. Middle East & Africa Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
8.5.4. Middle East & Africa Acquired Orphan Blood Disease Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Alexion Pharmaceuticals, Inc.
9.2.2. Amgen, Inc.
9.2.3. Celgene Corporation
9.2.4. Eli Lilly and Company
9.2.5. Sanofi S.A.
9.2.6. GlaxoSmithKline plc.
9.2.7. Cyclacel Pharmaceuticals, Inc.
9.2.8. Onconova Therapeutics, Inc.
9.2.9. Incyte Corporation
9.2.10. CTI BioPharma Corp.
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們